The effects of post-ovulatory administration of onapristone on the development of a secretory endometrium

Human Reproduction

Volumn 11, Issue 1, 1996, Pages 40-49

  Cameron, Sharon T ^a   Critchley, Hilary O D ^a   Buckley, C Hilary ^b   Chard, Tim ^c   Kelly, Rodney W ^a   Baird, David T ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Endometrial differentiation; Endometrium; Fertility control; Onapristone

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; CONTRACEPTIVE AGENT; ESTRADIOL; ESTROGEN RECEPTOR; FOLLITROPIN; HYDROCORTISONE; LUTEINIZING HORMONE; ONAPRISTONE; PLACENTA PROTEIN 14; PREGNANEDIOL; PROGESTERONE; PROGESTERONE RECEPTOR; SOMATOMEDIN BINDING PROTEIN 1;

ADULT; ARTICLE; BIRTH CONTROL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM BIOPSY; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HISTOLOGY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; HYDROCORTISONE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PROGESTERONE BLOOD LEVEL; RECEPTOR DOWN REGULATION;

EID: 0030066575     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.humrep.a019032     Document Type: Article

References (38)

1. Baird, D.T. (1993) Potential contraceptive effects of antigestogens. In Donaldson, M., Dorflinger, L., Brown, S.S. and Benet, L.Z. (eds). Clinical Applications of Mifepristone (RU486) and Other Antiprogestins. National Academy Press, Washington, DC, USA, pp. 148-163.
2. Bell, S.C., Jackson, J.A., Ashmore, J., Zhu, H.U. and Tseng, L. (1991) Regulation of insulin-like growth factor binding protein-1 synthesis and secretion by progestin and relaxin in long term cultures of human endometrial stromal cells. J. Clin. Endocrinol. Metab., 72, 1014-1024.
3. Berthois, Y., Salat-Baroux, J., Cornet, D., De Brux, J., Kopp, F. and Martin, P.M. (1991) A multiparametric analysis of endometrial estrogen and progesterone receptors after the postovulatory administration of mifepristone. Fertil. Steril., 55, 547-554.
4. Bolton, A.E., Pockley, A.G., Clough, K.J., Mowles, E.A., Stoker, R.J. et al. (1987) Identification of placental protein 14 as an immunosuppressive factor in human reproduction. Lancet, i, 593-595.
5. Cameron, S.T., Thong, K.J. and Baird, D.T. (1995) Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth. Clin. Endocrinol., 43, 407-414.
6. Casey, M.L., Hemsell, D.L., Macdonald, P.C. and Johnston, J.M. (1980) NAD dependent 15OH PG dehydrogenase activity in human endometrium. Prostaglandins, 19, 115-122.
7. Chard, T. (1994) Insulin-like growth factors and their binding proteins in normal and abnormal human fetal growth. Growth Regul., 4, 91-100.
8. Chard, T. and Olajide, F. (1994) Endometrial protein PP14: a new test of endometrial function? Reprod. Med. Rev., 3, 43-52.
9. Cheng, L. Kelly, R.W., Thong, K.J., Hume, R. and Baird, D.T. (1993) The effects of mifepristone (RU 486) on prostaglandin dehydrogenase in decidual and chorionic tissue in early pregnancy. Hum. Reprod., 8, 705-709.
10. Cordell, J.L , Falini, B., Erber, W.N., Ghosh, A.K., Abdulaziz, Z et al. (1984) Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (ARAAP complexes). J. Histochem Cytochem., 32, 219-229.
11. Critchley, H.O.D., Bailey, D.A., Au, C.L., Aflandi, B. and Rogers, P.A.W. (1993) Immunohistochemical sex steroid receptor distribution in endometrium from long-term subdermal levonorgestrel users and during the normal menstrual cycle. Hum. Reprod., 8, 1632-1639.
12. Croxatto, H.B., Salvatierra, A.M., Croxatto, H.D., Fuentealba, B., Zurth, C. and Beier, S. (1994) Effect of the antiprogestin onapristone on follicular growth in women. Hum. Reprod., 9, 1442-1447.
13. Garcia, E., Bouchard, P., De Brux, J., Berdah, J., Frydman, R. et al. (1988) Use of immunohistochemistry of progesterone and estrogen receptors for endometrial dating. J. Clin. Endocrinol Metab., 67, 80-87.
14. Garzo, V.G., Liu, J., Ulmann, A., Baulieu, E. and Yen, S.S.C. (1988) Effects of an antiprogesterone (RU 486) on the hypothalamic-hypophyseal ovarian-endometrial axis during the luteal phase of the menstrual cycle. J. Clin. Endocrinol Metab., 66, 508-517.
15. Gemzell-Danielsson, K., Swahn, M.-L., Svalander, P. and Bygdeman, M. (1993) Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod., 8, 870-873.
16. Gemzell-Danielsson, K., Svalander, P., Swahn, M.-L., Johannisson, E. and Bygdeman, M. (1994) Effects of a single post-ovulatory dose of RU 486 on endometrial maturation in the implantation phase. Hum. Reprod., 9, 2398-2404.
17. Glasier, A.F., Thong, K.J., Dewar, M., Mackie, M. and Baird, D.T. (1992) Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. N. Engl. J. Med., 327, 1041-1044.
18. Henderson, D. (1987) Antiprogestational and antiglucocorticoid activities of some novel 11β-aryl substituted steroids. In Furr, B.J.A. and Wakeling, A.E. (eds), Pharmacology and Clinical Uses of Inhibitors of Hormone Secretion and Action. Balliere Tindall, London, UK, pp. 184-211.
19. Howell, R.J.S., Economides, D., Teisner, B., Farkas, A.G. and Chard, T. (1989) Placental proteins 12 and 14 in pre-eclampsia. Acta Obstet. Gynecol. Scand., 68, 237-240.
20. Li, T.-C., Dockery, P., Thomas, P., Rogers, A.W., Lenton, E.A. and Cooke, I D. (1988) The effects of progesterone receptor blockade in the luteal phase of normal fertile women Fertil. Steril., 50, 732-742.
21. Maentausta, O., Svalander, P., Gemzell-Danielsson, K., Bygdeman, M. and Vihko, R. (1993) The effects of an antiprogestin, mifepristone, and an antiestrogen, tamoxifen, on endometrial 17β-hydroxysteroid dehydrogenase and progestin and estrogen receptors during the luteal phase of the menstrual cycle: an immunohistochemical study. J. Clin. Endocrinol. Metab., 77, 913-918.
22. Noyes, R.W., Hertig, A.T. and Rock, J. (1950) Dating the endometrial biopsy Fertil. Steril., 1, 3-25.
23. Okamoto, N., Uchida, A., Takakura, K., Kariya, Y., Kanzaki, H., Riitinen, L. et al. (1991) Suppression by human placental protein 14 of natural killer cell activity Am. J. Reprod. Immunol., 26, 137-142.
24. Rutanen, E.-M., Koistinen, R., Sjoberg, J., Julkunen, M., Walstrom, T et al. (1986) Synthesis of placental protein 12 by human endometrium. Endocrinology. 118, 1067-1071.
25. Rutanen, E -M., Gonzales, E., Said, J. and Braunstein, G.D. (1991) Immunohistochemical localisation of the insulin-like growth factor binding protein-1 in female reproductive tissues by monoclonal antibodies. Endocr. Pathol. 2, 132-138.
26. Schaison, G., George, M., Lestrat, N., Reinberg, A. and Baulieu, E.-E. (1985) Effects of the antiprogesterone steroid RU 486 during midluteal phase in normal women. J. Clin. Endocrinol Metab., 61, 484-489.
27. Seppala, M., Koistinen, K. and Rutanen, E.M. (1994) Uterine endocrinology and paracrinology: insulin-like growth factor binding protein-1 and placental protein 14 revisited. Hum Reprod., 9, 917-925.
28. Shi, S.-R., Key, M.E. and Kalra, K.L. (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem., 39, 741-748.
29. Shi, Y., Ye, Z., He, C., Zhang, G., Xu, J., Van Look, P.F.A. and Fotherby, K. (1993) Pharmacokinetic study of RU 486 and its metabolites after oral administration of single doses to pregnant and non-pregnant women. Contraception, 48, 133-149.
30. Shoham, Di Carlo, C., Patel, A., Conway, G. and Jacobs, H. (1991) Is it possible to run a successful ovulation induction program based solely on ultrasound monitoring? The importance of endometrial measurements. Fertil. Steril. 56, 836-841.
31. Shoupe, D., Mishell, D.R., Lahteenmaki, P., Heikinheimo, O., Bigerson, L. et al (1987) Effects of the antiprogesterone RU 486 in normal women. I. Single dose administration in the mid-luteal phase. Am. J. Obstet. Gynecol., 157, 1415-1420.
32. Swahn, M.L., Bygdeman, M., Cekan, S., Xing, S., Masironi, B. and Johannisson, E. (1990) The effects of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium. Hum. Reprod., 5, 402-408.
33. Taylor, C.R., Shi, S.-R., Chaiwun, B., Young, L., Iman, S.A. and Cote, R. (1994) Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections. Hum. Pathol., 25, 263-270.
34. Waites, G.T., Wood, P.L., Walker, R.A. and Bell, S.C. (1988) Immunohistological localisation of human endometrial secretory protein, 'pregnancy-associated endometrial α2-globulin' (α2 PEG), during the menstrual cycle. J. Reprod. Fertil., 82, 665-672.
35. Walstrom, T. and Seppala, M. (1984) Placental protein 12 (PP12) induced in the endometrium by progesterone Fertil. Steril , 41, 781-784.
36. Wang, H.S., Perry, L.A , Kanisius, J., Iles, R.K., Holly, J.M.P. and Chard, T. (1991) Purification and assay of insulin-like growth factor binding protein-1: measurement of circulating levels throughout pregnancy. J. Endocrinol., 128, 161-168.
37. Yong, E.L., Glasier, A.F., Hillier, H.H., Ledger, W., Caird, L. et al. (1992) Effect of cyclofenil on hormone dynamics, follicular development and cervical mucus in normal and oligomenorrhoeic women. Hum. Reprod., 7, 39-43.
38. Zurth, C. and Kagels, F. (1990) Determination of onapristone and its N-desmethylmetabolite in human plasma or serum by high performance liquid chromatography. J. Chromatogr., 532, 115-123.